Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

A venture between GEA and Siemens aims to familiarize more pharmaceutical companies with more modern control and continuous processing.

Making PAT and Continuous Manufacturing Accessible

Johannes G. Khinast is professor at the Institute of Process and Particle Engineering, Graz University of Technology, Austria

Josef Lingitz is project manager, M&R Automation GmbH, Graz, Austria.

Sharareh Salar-Behzadi is principal scientist atResearch Center Pharmaceutical Engineering (RCPE)GmbH, Graz, Austria.

Stephan Sacher is senior scientist at the Research Center for Pharmaceutical Engineering GmbH in Graz, Austria.

This novel technology was developed in response to challenges involved in conventional manufacturing of multilayer tablets, including in-line control of the tablet weight, the tendency to delamination, direct contact between the two tablet layers, and cross contamination.

Gluing Pills Technology for the Production of Multi-Layer Tablets

Lawrence H. Block, PhD, is a professor of pharmaceutics at the School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, tel. 412.396.6362, fax 412.396.5599, block@duq.edu.

Catherine Sheehan is the director for the excipients group at the United States Pharmacopeia in Rockville, Maryland.

This article summarizes the evolution of the viscosity standards and their corresponding applications in the USP−NF compendia.

Characterization of Polymeric Excipients

Smruti P. Chaudhari, PhD, is a development scientist at Metrics Contract Services.

A case study reviews the reformulation and scale up of high drug load prototype using wet granulation process for a model formulation.

Wet Granulation Resolves Tablet Reformulation Challenges

The facility in Britley will now manufacture the company’s automated systems, enabling the company to better serve European markets and shorten the supply chain.

Parker Domnick Hunter to Manufacture Automated Bioprocessing Systems at UK Facility

The agency recommended six drugs for approval in March 2017 including treatments for neuroblastoma, heart failure, and more.

EMA Recommends Three Orphan Drugs for Approval

In a FDAVoice blog post, CBER Director Peter Marks discusses the new designation for cell therapies that treat life-threatening diseases.

Regenerative Medicine Advanced Therapy Designation Launches

Fisher BioServices will expand its CryoHub solution by co-locating it with the Cell and Gene Therapy Catapult manufacturing center for seamless supply chain management and to accelerate cell and gene therapy production.

Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Form Pact to Optimize Advanced Therapy Supply Chain

Manufacturing will be carried out at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract manufacturing network.

CMO Pfizer CentreOne Adds Highly Potent Solid Oral Dose to Portfolio

The ready-to-fill packaging solutions for vials are based on Ompi EZ-fill packaging design.